CNO Financial Group, Inc. (CNO-PA)

Current Report Filed: 2026-05-13

All nine board nominees were elected with strong shareholder support, with Gary C. Bhojwani receiving the highest vote count (81.2M for votes), indicating confidence in current board leadership and governance structure.
Executive compensation received non-binding advisory approval with 79.6M votes in favor versus 1.7M against, demonstrating general shareholder acceptance of the company's pay practices despite some minority opposition.
PricewaterhouseCoopers LLP was ratified as independent auditor with overwhelming support (83.9M votes for), reflecting continued confidence in the audit function and financial reporting oversight.
Broker non-votes of 4.3M on director elections represent approximately 5% of total voting shares, suggesting significant institutional shareholder participation and engagement with the annual meeting process.

Insider Trading Filed: 2026-05-13

Director Archie M. Brown acquired 3,574 shares of CNO Financial Group common stock on 05/12/2026 at $46.17 per share, representing a restricted stock unit award that immediately vested under the company's Long-Term Incentive Plan.
Brown's total beneficial ownership increased to 20,337 shares following this transaction, indicating continued alignment with shareholder interests through direct equity ownership.
The acquisition was executed as part of the company's standard equity compensation program rather than through open market purchases, suggesting routine director compensation rather than discretionary insider buying conviction.

Insider Trading Filed: 2026-05-13

Director Lee Adrianne acquired 3,574 shares of CNO common stock at $46.17 per share on 05/12/2026 through an award of immediately vesting restricted stock units, indicating compensation alignment with shareholder interests.
The transaction represents a relatively modest equity award (~$165K value) for a director-level position, suggesting measured executive compensation practices at CNO Financial Group.
Post-transaction beneficial ownership of 20,337 shares indicates established long-term holdings in the company, demonstrating director confidence in CNO's business and strategic direction.

Insider Trading Filed: 2026-05-13

Director David B. Foss acquired 3,574 restricted stock units (RSUs) on 05/12/2026 valued at approximately $165,000 at the grant price of $46.17, indicating equity compensation aligned with shareholder interests.
The RSUs were granted as immediately vesting awards under CNO's Long-Term Incentive Plan, suggesting the company maintains executive retention programs through equity grants.
Foss's indirect beneficial ownership through the Foss Management Trust increased to 52,725 shares total, demonstrating meaningful personal investment in the company's performance.
The transaction represents routine equity compensation rather than open market buying, limiting it as a signal of insider confidence in the stock's future direction.

Insider Trading Filed: 2026-05-13

Director Daniel R. Maurer acquired 6,043 shares of CNO common stock on 05/12/2026 at $46.17 per share through an award of immediately vesting restricted stock units (RSUs), representing compensation rather than discretionary market purchases.
Maurer's total beneficial ownership increased to 108,102 shares directly held plus 24,624 shares indirectly held through the Daniel R. Maurer Revocable Trust, indicating meaningful accumulated equity stake in the company.
The transaction represents routine director compensation through equity grants under the Long-Term Incentive Plan rather than insider trading activity, with no indication of management's sentiment about near-term stock performance.

Insider Trading Filed: 2026-05-13

Director Ragavan Chetlur acquired 3,574 shares of CNO common stock on 05/12/2026 at $46.17 per share through an award of immediately vesting restricted stock units, bringing total beneficial ownership to 33,325 shares.
This is a modest equity compensation award typical of director compensation under the company's Long-Term Incentive Plan, indicating regular governance-level incentive alignment rather than significant insider conviction.
The immediate vesting of the RSU grant suggests this is part of standard annual or periodic director compensation rather than a performance-based or time-vested equity award, which is routine for board members.

Insider Trading Filed: 2026-05-13

Director Steven E. Shebik acquired 3,574 shares of CNO common stock on 05/12/2026 at $46.17 per share through an award of immediately vesting restricted stock units, bringing his total beneficial ownership to 56,756 shares.
This acquisition represents equity compensation rather than open market purchases, which is typical for director compensation but provides modest insight into insider confidence at current valuation levels.
The filing shows no derivative securities transactions or option exercises, indicating the compensation was granted as restricted stock rather than performance-based equity awards.

Insider Trading Filed: 2026-05-13

Director Jessica A Turner acquired 3,574 shares of CNO common stock on 05/12/2026 at $46.17 per share, representing an award of immediately vesting restricted stock units (RSUs) under the company's Long-Term Incentive Plan rather than a discretionary open market purchase.
Turner's total beneficial ownership increased to 10,584 shares following this transaction, indicating meaningful accumulated equity stake as a board member and demonstrating confidence in the company through compensation structure alignment with shareholders.
The transaction is routine compensation-related activity rather than significant insider buying or selling, as RSU awards are standard director compensation and provide limited insight into management's views on current valuation or company prospects.

Insider Trading Filed: 2026-05-13

Director Linda T. Gibson acquired 3,574 shares of CNO common stock on 05/12/2026 at $46.17 per share through an award of immediately vesting restricted stock units (RSUs), indicating compensation alignment with shareholder interests.
The shares were acquired indirectly through the Linda T. Gibson Revocable Trust Agreement, bringing total indirect beneficial ownership to 4,817 shares, suggesting structured estate planning by a board member.
This is a routine equity compensation transaction for a director under the company's Long-Term Incentive Plan, with no indication of significant insider buying conviction or market timing concerns.

Insider Trading Filed: 2026-05-11

Karen J. DeToro, President of the Worksite Division, disposed of 4,400 shares of CNO common stock on 05/11/2026 through a charitable donation, indicating a non-market transaction rather than a stock sale.
Following the transaction, DeToro maintains beneficial ownership of 46,124 shares, demonstrating continued significant equity stake in the company despite the charitable contribution.
The transaction was executed at $0 price per share due to its charitable nature, making it a non-indicative insider activity that does not signal bearish sentiment about the stock's value.

Quarterly Report Filed: 2026-05-07

Q1 2026 10-Q filing shows the company maintains diversified investment portfolio across fixed maturities, mortgages, and government securities, indicating broad-based asset management and risk distribution.
The filing contains detailed disclosures on debt-to-value ratios for commercial mortgage segments across multiple LTV tiers (under 60% through 90%+), suggesting active monitoring of credit quality and real estate exposure.
Multiple preferred stock series and subordinated debt instruments ($125 Subordinated Debentures Due 2060) indicate a layered capital structure with various maturity profiles and subordination levels for liability management.

Current Report Filed: 2026-04-30